Manufacturer record
Vobb Healthcare: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Vobb Healthcare (Himachal Pradesh) was declared Not of Standard Quality in January 2023. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: VGT11028, Erythromycin Stearate Tablets IP 250 mg (Erycon?-250) (exp Sep 2024). RDTL Guwahati (state lab) found it not of standard quality: Dissolution. Listed in the January 2023 alert.
Records by type
1 record linked to Vobb Healthcare in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Erythromycin Stearate Tablets IP 250 mg (Erycon?-250) | Batch VGT11028Mfg Oct 2021 · Exp Sep 2024 | DissolutionDissolution | RDTL GuwahatiState lab | Jan 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.